GLEAM Clinical Trial Recruitment Dinner
Other
240 Union Boulevard,Lakewood CO 80228
13 January, 2022
Description
Educational dinner event for OD's & MD's to learn about the efficacy and safety of a new injection treatment, KSI-301 for patients with DME. Colorado Retina Associates offers a robust, in-house clinical research program to all of our patients. As a practice we participate in some of the most innovative research and clinical trials surrounding retina treatments, diagnosis, and cures for blindness. Currently the Colorado Retina Research Department is enrolling a phase 3 study of an investigational drug called KSI-301, being developed by Kodiak Sciences, for the possible treatment of patients with decreased vision associated with retinal vascular disorders, such as diabetic macular edema (DME). Over a four-course complimentary dinner, Colorado Retina's Dr. Brian Joondeph, PI on the study, will review the retinal anatomic effects, durability profile, and efficacy and safety data surrounding KSI-301 in the treatment of DME compared with the standard of care treatment using the drug aflibercept. Like aflibercept, KSI-301 is designed to decrease fluid leakage and swelling of the retina by blocking VEGF, a protein in the eye called vascular endothelial growth factor. When there is too much VEGF inside the eye because of damage to the retina from diabetes, swelling and bleeding can occur resulting in vision loss. The purpose of this dinner is to spread awareness for this important potential advancement in the treatment for DME. If approved, KSI-301 will last longer in the eye compared to the standard injection treatment and thus fewer injections of KSI-301 may be needed over time by patients. IMPORTANT: Admission is complimentary and open to all licensed, practicing optometrists and ophthalmologists. Space is limited, you must save your spot on Eventbrite to attend. You must be fully vaccinated against COVID-19 to attend, vaccine cards will be checked at the door. No CE credit will be awarded for attendance, this event is for educational purposes only.
Discussion
By posting you agree to the Terms and Privacy Policy.